Screener
Teladoc Health TDOC Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Teladoc Health’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:54 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001477449-26-000038
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash flows from operating activities: | ||
| Goodwill impairment | — | 59,138 |
| Amortization of intangible assets | 178,268 | 172,968 |
| Stock-based compensation | 23,912 | 47,507 |
| Depreciation of property and equipment | 4,929 | 7,902 |
| Amortization of right-of-use assets | 3,394 | 4,190 |
| Provision for allowances for doubtful accounts | 807 | 377 |
| Deferred income taxes | (1,673) | (34,072) |
ITEM 1. Financial Statements
FAQ
- What is Teladoc Health's stock-based comp?
- Teladoc Health (TDOC) reported stock-based comp of $9.3M in Q2 2026.
- How has Teladoc Health's stock-based comp changed year-over-year?
- Teladoc Health's stock-based comp decreased by 58.4% year-over-year, from $22.34M to $9.3M.
- What is the long-term trend for Teladoc Health's stock-based comp?
- Over 4 years (2021 to 2025), Teladoc Health's stock-based comp has grown at a -28.2% compound annual growth rate (CAGR), from $302.59M to $80.41M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Teladoc Health's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude